Multiple Assemblies exist for SMTL entry 4w9e
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 4); X-RAY DIFFRACTION 2.60 Å

	SMTL ID 4w9e.1 Ligands (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(1,3-thiazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9e.2 Ligands (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(1,3-thiazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9e.3 Ligands (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(1,3-thiazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9e.4 Ligands (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(1,3-thiazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer